Under the agreement, Syngenta will evaluate KOMO’s non-viral, integrase-based genome engineering technology for research applications focused on the controlled and predictable introduction of genetic ...
With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...
News-Medical.Net on MSN
Researchers develop DNA aptamer to detect Alzheimer's biomarkers
With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...
The Central Drugs Standard Control Organization (CDSCO) has announced that all applications related to Post Approval Changes (PAC) for recombinant DNA (r-DNA) products must now ...
University of Dundee experts will harvest knowledge from some of our favourite fruits to learn more about how plants remember ...
Rising Prevalence of Cancer and Chronic Diseases, Demand for Personalized and Precision Medicine, and Integration with Multiomics and AI, Accelerate Demand for EpigeneticsNew York - NY, March 11, 2026 ...
Cancers emerge from many different paths. One path begins early, in embryonic development, when a protein complex called PRC2, which regulates cell differentiation, identity, and plasticity, becomes ...
AZoLifeSciences on MSN
How SARS-CoV-2 hijacks host tRNA chemistry to sustain infection
Findings reveal coronaviruses exploit stress-linked tRNA modifications, enhancing translation efficiency and offering insights for antiviral drug development.
A Formula 1 increasingly reliant on electric power and battery technology appears to be starting to attract major players from the EV automotive sector. On Tuesday, Bloomberg reported that BYD - the ...
Full Circles Therapeutics today announced that its circular single-stranded DNA (cssDNA, C4DNAtm) technology platform has been highlighted as a key enabling component of a new genome engineering ...
Researchers created long noncoding RNA targeting inflammatory pathways. The approach reduced cytokine production in human cell cultures and mouse models, demonstrating a novel strategy for RNA-based ...
Explore the breakthrough of lab-made lncRNA by University of Toronto Engineering for new drug discovery potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results